CDKN2A and cancer: While transgenic HGF mice were predisposed to a low incidence of many types of cancers, including skeletal muscle-derived tumors [43], transgenic HGF mice with a targeted deletion of the INK4A/ARF locus had a near complete penetrance of eRMS in young animals [44].